Munehiro Kitada
Impact in
- Geriatrics and Gerontology top 0.1%
- Sirtuins and Resveratrol in Medicine
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 22
- Co-authors
- Daisuke Koya (88 shared papers)Yoshio Ogura (29 shared papers)Keizo Kanasaki (48 shared papers)Itaru Monno (19 shared papers)Shinji Kume (9 shared papers)Swayam Prakash Srivastava (11 shared papers)Takako Nagai (14 shared papers)Sen Shi (9 shared papers)
- Journals
- Journal of Diabetes Investigation (8 papers)Drug Metabolism and Disposition (4 papers)Scientific Reports (4 papers)Diabetes (4 papers)Xenobiotica (4 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Munehiro Kitada
118 papers receiving 7.2k citations
Munehiro Kitada's Hit Papers
Peers
Comparison fields: 5 of 129
- Geriatrics and Gerontology 960
- Nephrology 962
- Clinical Biochemistry 652
- Endocrinology, Diabetes and Metabolism 1.3k
- Pharmacology 587
Countries citing papers authored by Munehiro Kitada
This map shows the geographic impact of Munehiro Kitada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Munehiro Kitada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Munehiro Kitada more than expected).
Fields of papers citing papers by Munehiro Kitada
This network shows the impact of papers produced by Munehiro Kitada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Munehiro Kitada. The network helps show where Munehiro Kitada may publish in the future.
Co-authors
The 25 scholars most cited alongside Munehiro Kitada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 312 | |
| 2 | 2014 | 304 | |
| 3 | Autophagy in metabolic disease and ageing Hit paper breakdown → | 2021 | 298 |
| 4 | 2003 | 251 | |
| 5 | 2013 | 231 | |
| 6 | 2016 | 230 | |
| 7 | 2019 | 226 | |
| 8 | 2016 | 205 | |
| 9 | Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules Hit paper breakdown → | 2020 | 197 |
| 10 | 2011 | 194 | |
| 11 | 2003 | 191 | |
| 12 | 2012 | 188 | |
| 13 | 2012 | 183 | |
| 14 | 2010 | 162 | |
| 15 | 2013 | 150 | |
| 16 | 1987 | 150 | |
| 17 | 1994 | 140 | |
| 18 | 2018 | 139 | |
| 19 | 2011 | 132 | |
| 20 | 2015 | 132 |
About Munehiro Kitada
Munehiro Kitada is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Physiology, Geriatrics and Gerontology and Epidemiology, having authored 123 papers that have together received 7.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (22 papers), Sirtuins and Resveratrol in Medicine (22 papers), Chronic Kidney Disease and Diabetes (16 papers), Adipose Tissue and Metabolism (15 papers), Autophagy in Disease and Therapy (15 papers), Pharmacogenetics and Drug Metabolism (11 papers), Pancreatic function and diabetes (10 papers) and Biochemical effects in animals (7 papers). The work is most often cited by research in Geriatrics and Gerontology (960 citations), Nephrology (962 citations), Clinical Biochemistry (652 citations), Endocrinology, Diabetes and Metabolism (1.3k citations) and Pharmacology (587 citations). Munehiro Kitada has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Daisuke Koya, Yoshio Ogura, Keizo Kanasaki, Itaru Monno, Shinji Kume, Swayam Prakash Srivastava, Takako Nagai, Sen Shi, Jinpeng Li and Yuta Takagaki. Their work appears in journals such as Journal of Diabetes Investigation, Drug Metabolism and Disposition, Scientific Reports, Diabetes and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.